Using a 100 µL sample size, most of the tested analytes were recovered at 70 percent or greater. The analytical response for the extracted analytes with high matrix effects was sufficient to achieve adequate recoveries and LODs. This method, therefore, supports the use of ISOLUTE® SLE+ for the screening of urine samples for various illicit and prescribed drugs.
Codeine, hydrocodone, oxycodone, norcodeine, oxymorphone, 6-acetyl codeine, alprazolam, clonazepam, diazepam, flunitrazepam, nitrazepam, oxazepam, temazepam, dextromethorphan, buprenorphine, norbuprenorphine, fentanyl, EDDP, benzoylecgonine, tetrahydrocannabinol, normeperidine, naltrexone, hydromorphone, propoxyphene, pentazocine, amphetamine, norfentanyl, MDEA, butalbital, pentobarbital, phenobarbital, secobarbital, 11-nor-9 –carboxy- Δ9-tetrahydrocannabinol, and d3-11-hydroxy-tetrahydrocannabinol.
Download the application note below.
Webinar Recording: Developing a Comprehensive Urine Pain Panel
How to Develop a Scalable Metals Removal Process in Chemistry
Extraction of Phosphatidylethanol Species from Whole Blood Using ISOLUTE® SLE+
Automated Fractionation of Extractable Petroleum Hydrocarbons (EPH) in Soil
Current Methodologies for Drugs of Abuse Urine Testing